Treating the potentially blinding haze of a scar on the cornea might be as straightforward as growing stem cells from a tiny biopsy of the patient’s undamaged eye and then placing them on the injury site, according to mouse model experiments conducted by researchers at the University of Pittsburg
You are here
Coverage of the latest news and updates from the field of stem cells and regenerative medicine.
Researchers from the Broad Institute of MIT and Harvard, Harvard Medical School and Harvard-affiliated hospitals have uncovered an easily detectable, “pre-malignant” state in the blood that significantly increases the likelihood that an individual will go on to develop bl
A new drug that fights the stem cells that cause the onset and development of cancer has proved to be effective in tests on mice. The drug, Bozepinib, shows a selective type of activity against cancerogenic stem cells in breast, colon, and skin cancers.
Why bones grow longer and stronger in children but stay static in adults, yet retain the ability to heal themselves, has long perplexed scientists.
Induced pluripotent stem cells made from patients with a form of blistering skin disease can be genetically corrected and used to grow back healthy skin cells in laboratory dishes, researchers at the Stanford University School of Medicine have found.
One remarkable quality of pluripotent stem cells is they are able to divide and grow indefinitely under the right conditions. It turns out that this ability might also exist further down the development path, with the workhorse progenitor cells responsible for creating specific tissues.
Researchers have uncovered the role of certain stem cells in regenerating lungs damaged by disease, shedding light on the inner workings of lung regeneration and pointing to potential therapeutic strategies that harness these lung stem cells.
A team of researchers in France has developed a new approach to control the differentiation of human pluripotent stem cells and produce different populations of motor neurons from these cells in only 14 days.
Researchers report that they have identified two proteins that appear crucial to the development—and patient relapse—of acute myeloid leukemia. They have also shown they can block the development of leukemia by targeting those proteins.